These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 204756)

  • 1. Tc-99m pyrophosphate muscle labeling in McArdle syndrome.
    Swift TR; Brown M
    J Nucl Med; 1978 Mar; 19(3):295-7. PubMed ID: 204756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle accumulation of Tc-99m diphosphonate in myophosphorylase deficiency and other disorders of muscle glycogenolysis/glycolysis.
    Brumback RA
    Clin Nucl Med; 1983 Apr; 8(4):165-6. PubMed ID: 6573990
    [No Abstract]   [Full Text] [Related]  

  • 3. [Scintigraphic demonstration of a iatrogenic rhabdomyolysis in McArdle's syndrome (author's transl)].
    Neumann P; Rumpf KW; Kaiser H; Meinck HM; Goebel HH; Schicha H; Emrich D
    Nuklearmedizin; 1982 Feb; 21(1):12-5. PubMed ID: 6210883
    [No Abstract]   [Full Text] [Related]  

  • 4. Accumulation of 99mTc-pyrophosphate in a muscle hernia of the thigh.
    Shigeno C; Fukunaga M; Yamamoto I; Morita R; Hino M; Torizuka K; Kodama Y; Kawashima T
    Eur J Nucl Med; 1981; 6(9):425-8. PubMed ID: 6268413
    [No Abstract]   [Full Text] [Related]  

  • 5. Muscle necrosis in the extremities: evaluation with Tc-99m pyrophosphate scanning--a retrospective review.
    Timmons JH; Hartshorne MF; Peters VJ; Cawthon MA; Bauman JM
    Radiology; 1988 Apr; 167(1):173-8. PubMed ID: 2831562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro parameters of skeletal muscle trophism in haemophilia.
    Mariani G; Panicucci F; Mazzuca N; Del Chicca MG; Molea N; Pitruzzello S; Positano M; Clerico A; Gandini S
    J Nucl Med Allied Sci; 1984; 28(2):85-90. PubMed ID: 6096526
    [No Abstract]   [Full Text] [Related]  

  • 7. Tc-99m pyrophosphate myocardial imaging in perimyocarditis.
    Ahmad M; Dubiel JP
    J Nucl Med; 1981 May; 22(5):452-4. PubMed ID: 6260911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative evaluation of 99mTc-pyrophosphate muscle uptake in patients with inflammatory and noninflammatory muscle diseases.
    Bellina CR; Bianchi R; Bombardieri S; Ferri C; Mariani G; Muratorio A; Rossi B
    J Nucl Med Allied Sci; 1978; 22(2):89-96. PubMed ID: 213542
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential Muscle Involvement in Mice and Humans Affected by McArdle Disease.
    Krag TO; Pinós T; Nielsen TL; Brull A; Andreu AL; Vissing J
    J Neuropathol Exp Neurol; 2016 May; 75(5):441-54. PubMed ID: 27030740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment and McArdle disease: Is there a link?
    Mancuso M; Orsucci D; Volterrani D; Siciliano G
    Neuromuscul Disord; 2011 May; 21(5):356-8. PubMed ID: 21382715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease?
    de Luna N; Brull A; Lucia A; Santalla A; Garatachea N; Martí R; Andreu AL; Pinós T
    Neuromuscul Disord; 2014 Dec; 24(12):1079-86. PubMed ID: 25240406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of Tc-99m pyrophosphate in muscle after exercise.
    Lentle BC; Percy JS; Rigal WM; Russell AS
    J Nucl Med; 1978 Feb; 19(2):223-4. PubMed ID: 203668
    [No Abstract]   [Full Text] [Related]  

  • 13. Technetium pyrophosphate muscle scans in inflammatory muscle disease.
    Yonker RA; Webster EM; Edwards NL; Katz P; Longley S; Petterssen H; Panush RS
    Br J Rheumatol; 1987 Aug; 26(4):267-9. PubMed ID: 3038250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [McArdle disease: report of four brothers with myophosphorylase deficiency].
    López Martín A; Baños Madrid RI; García-Estañ Candela J; García Pérez B; Pérez Bautista FJ; Salmerón P
    An Med Interna; 2001 Mar; 18(3):136-8. PubMed ID: 11594178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tc-99m methylene diphosphonate versus Tc-99m pyrophosphate: biologic and clinical comparison.
    Rudd TG; Allen DR; Hartnett DE
    J Nucl Med; 1977 Sep; 18(9):872-6. PubMed ID: 197133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proposals for the preparation and testing of radiopharmac critical agents. Proposal for the preparation and testing of 99m Tc-Sn pyrophosphate for bone scintigraphy].
    Charamza O
    Cesk Farm; 1974 Sep; 23(7):290. PubMed ID: 4373179
    [No Abstract]   [Full Text] [Related]  

  • 17. The forearm ischaemic work test--hazardous to McArdle patients?
    Meinck HM; Goebel HH; Rumpf KW; Kaiser H; Neumann P
    J Neurol Neurosurg Psychiatry; 1982 Dec; 45(12):1144-6. PubMed ID: 6962283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Important advances in bone scintigraphy by use of technetium pyrophosphate (99m Tc)].
    Rain JD; Kuntz D; Najean Y
    Nouv Presse Med; 1973 Jan; 2(3):186. PubMed ID: 4346426
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical comparison of technetium-99m diphosphonate and pyrophosphate in bone scintigraphy: concise communication.
    Silberstein EB; Maxon HR; Alexander GW; Rauf C; Bahr GK
    J Nucl Med; 1978 Feb; 19(2):161-3. PubMed ID: 203665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of iron on the biodistribution of bone scanning agents in humans.
    Choy D; Murray IP; Hoschl R
    Radiology; 1981 Jul; 140(1):197-202. PubMed ID: 6264545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.